Obesity and Type 2 Diabetes are Associated with an Increased Risk of Developing Cancer and a Worse Prognosis; Epidemiological and Mechanistic Evidence

Abstract

Both obesity and Type 2 diabetes are independently associated with an increased risk of developing cancer and an increased mortality. The etiology is yet to be determined but insulin resistance and hyperinsulinemia maybe important factors. Hyperglycemia, hyperlipidemia and inflammatory cytokines in addition to the insulin-like growth factors are also possible factors involved in the process.

Key words

diabetes - obesity - cancer - epidemiology

References

• 1 Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults.  N Engl J Med. 2003;  348 1625-1638
• 2 Adams TD, Gress RE, Smith SC. et al . Long-term mortality after gastric bypass surgery.  N Engl J Med. 2007;  357 753-761
• 3 Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults.  Am J Epidemiol. 2004;  159 1160-1167
• 4 Polednak AP. Trends in incidence rates for obesity-associated cancers in the US.  Cancer detection and prevention. 2003;  27 415-421
• 5 Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer Statistics, 2007.  CA Cancer J Clin. 2007;  57 43-66
• 6 Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies.  The Am J Clin Nutr. 2007;  86 556-565
• 7 Dignam JJ, Polite BN, Yothers G. et al . Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.  J Natl Cancer Inst. 2006;  98 1647-1654
• 8 Michels KB, Solomon CG, Hu FB. et al . Type 2 Diabetes and subsequent incidence of breast cancer in the nurses’ health study.  Diabetes Care. 2003;  26 1752-1758
• 9 Ogden CL, Carroll MD, Curtin LR, MacDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States 1999–2004.  Jama. 2006;  295 1549-1555
• 10 Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms.  Nat Rev Cancer. 2004;  4 579-591
• 11 Samani AA, Yakar S, LeRoith D, Brodt P. The role of the IGF system in cancer growth and metastasis: overview and recent insights.  Endocr Rev. 2007;  28 20-47
• 12 Ristow M. Oxidative metabolism in cancer growth.  Curr Opin Clin Nutr Metab Care. 2006;  9 339-345
• 13 Yakar S, Nunez NP, Pennisi P. et al . Increased tumor growth in mice with diet-induced obesity: impact of ovarian hormones.  Endocrinology. 2006;  147 5826-5834
• 14 Fernandez AM, Kim JK, Yakar S. et al . Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes.  Genes Dev. 2001;  15 1926-1934
• 15 Novosyadlyy R, Lann D, Rowzee A, Lazzarino DA, Pennisi PA, Kurshan N, Mejia W, Santopietro S, Yakar S, Wood TL, LeRoith D. Type 2 Diabetes Accelerates Normal Mammary Gland Development and Breast Cancer Progression. Abstract #1326-P American Diabetes Association Scientific Sessions June 2008

Correspondence